Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs Nkarta, Inc. (NKTX)

Foghorn Therapeutics Inc. and Nkarta, Inc. are both Biotechnology companies. Foghorn Therapeutics Inc. and Nkarta, Inc. are of similar size ($113.1M and $112.5M). Nkarta, Inc. has the higher net margin (0.00% vs −175.8%) and the lower return on invested capital (−127.2% vs 0.00%). Across the 13 metrics below, Foghorn Therapeutics Inc. leads on 8 and Nkarta, Inc. on 5.

Valuation

Metric FHTX NKTX Biotechnology median
P/E n/m n/m 10.60
P/S 3.60 n/m 9.40
P/B n/m 0.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.22 0.42 0.66
EV/Sales (0.42) n/m 9.02
Earnings yield (52.41%) (89.71%) (32.88%)
Free cash flow yield (63.84%) (72.03%) (23.13%)

Profitability

Metric FHTX NKTX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (198.04%) 0.00% 0.00%
Net margin (175.78%) 0.00% 0.00%
Free cash flow margin (229.49%) 0.00% 0.00%
Return on equity 81.90% (38.76%) (51.96%)
Return on assets (30.06%) (29.86%) (46.06%)
Return on invested capital 0.00% (127.22%) 0.00%

Growth

Metric FHTX NKTX Biotechnology median
Revenue growth (TTM) 51.98% — 6.76%
EPS growth (last fiscal year) 25.32% 11.88% 29.88%
Revenue growth, 5-year CAGR 135.14% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX NKTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 7.98 4.97
Net debt to EBITDA 1.88 2.35 1.01

Dividend

Metric FHTX NKTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FHTX NKTX Biotechnology median
Market cap 113.13m 112.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack